Regeneron Pharmaceuticals
(REGN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2015 | 06-2015 | 03-2015 | 12-2014 | 09-2014 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 654,587 | 390,554 | 507,907 | 648,719 | 646,554 |
| Marketable Securities | 241,055 | 213,694 | 234,257 | 251,761 | 395,650 |
| Receivables | 1,439,315 | 1,395,125 | 1,338,462 | 976,372 | 927,254 |
| Inventories | 190,668 | 171,266 | 133,863 | 128,861 | 120,317 |
| Income taxes - deferred | 60,521 | 69,603 | 62,126 | N/A | 49,005 |
| TOTAL | $2,675,640 | $2,283,341 | $2,310,714 | $2,084,759 | $2,200,512 |
| Non-Current Assets | |||||
| PPE Net | 1,475,123 | 1,326,112 | 1,110,597 | 974,309 | 818,967 |
| Investments And Advances | 681,326 | 589,595 | 483,305 | 460,154 | 453,443 |
| Other Non-Current Assets | 350,826 | 327,922 | 293,957 | 318,450 | 266,497 |
| TOTAL | $2,507,275 | $2,243,629 | $1,887,859 | $1,752,913 | $1,538,907 |
| Total Assets | $5,182,915 | $4,526,970 | $4,198,573 | $3,837,672 | $3,739,419 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 577,428 | 529,505 | 462,762 | 483,489 | 337,976 |
| Other current liabilities | 2,506 | 2,291 | 2,185 | 97,146 | N/A |
| TOTAL | $734,990 | $601,542 | $536,134 | $654,660 | $410,200 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 155,056 | 69,746 | 71,187 | 74,025 | 70,972 |
| Other Non-Current Liabilities | 108,633 | 106,440 | 199,641 | 186,574 | 311,697 |
| TOTAL | $1,151,058 | $586,970 | $691,009 | $632,761 | $777,431 |
| Total Liabilities | $1,886,048 | $1,188,512 | $1,227,143 | $1,287,421 | $1,187,631 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 104,065 | 103,688 | 103,278 | 102,617 | 101,665 |
| Common Shares | 108 | 107 | 105 | 104 | 102 |
| Retained earnings | 697,706 | 487,308 | 292,665 | 216,644 | 145,206 |
| Other shareholders' equity | 7,944 | 19,074 | 48,087 | 52,721 | 27,046 |
| TOTAL | $3,296,867 | $3,338,458 | $2,971,430 | $2,550,251 | $2,551,788 |
| Total Liabilities And Equity | $5,182,915 | $4,526,970 | $4,198,573 | $3,837,672 | $3,739,419 |